/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | URGNUroGen Pharma Ltd. |
|---|---|
| Last close | $33.91 |
| Change % | -0.38% |
| Market cap | $1.7B |
| P/E | — |
| Revenue | $110M |
| Rev growth (YoY) | 21.4% |
| Net income | $-153494000 |
| Net margin | -139.8% |
| EPS (diluted) | $-4.96 |
| Piotroski F-ScoreUNVALIDATED | 1 |
| Altman Z-ScoreUNVALIDATED | -4.12 |
| Beneish M-ScoreUNVALIDATED | -1.42 |
| Next earnings | 10-31 → 11-10 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.